News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vernalis PLC (VNLS) Signs Agreement With Diosynth Biotechnology (Research Triangle Park) For Phase III Manufacture Of V10153



10/19/2005 5:12:29 PM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Sept. 22, 2005--Vernalis Plc has signed a contract with Diosynth Biotechnology for process development, scale-up and manufacturing of V10153 for Phase III clinical trials.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES